Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
2.2M
-
Number of holders
-
28
-
Total 13F shares, excl. options
-
192K
-
Shares change
-
+169K
-
Total reported value, excl. options
-
$623K
-
Value change
-
+$550K
-
Number of buys
-
25
-
Number of sells
-
-3
-
Price
-
$3.22
Significant Holders of Alaunos Therapeutics, Inc. - Common Stock (TCRT) as of Q3 2024
30 filings reported holding TCRT - Alaunos Therapeutics, Inc. - Common Stock as of Q3 2024.
Alaunos Therapeutics, Inc. - Common Stock (TCRT) has 28 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 192K shares
of 2.2M outstanding shares and own 8.72% of the company stock.
Largest 10 shareholders include MSD Partners, L.P. (101K shares), VANGUARD GROUP INC (45.3K shares), BlackRock, Inc. (22.2K shares), GEODE CAPITAL MANAGEMENT, LLC (16.3K shares), MORGAN STANLEY (1.34K shares), UBS Group AG (1.03K shares), OSAIC HOLDINGS, INC. (867 shares), Tower Research Capital LLC (TRC) (640 shares), GROUP ONE TRADING LLC (458 shares), and Sugarloaf Wealth Management, LLC (435 shares).
This table shows the top 28 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.